Skip to main content

Table 1 Comparison of genomic alterations pre- and post-pazopanib resistance

From: Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine

Gene Name

Panel1

WES1

WES2

Impact of Mutation

cDNA change

aa change

mutant reads

coverage

VAF

cDNA change

aa change

mutant reads

coverage

VAF

cDNA change

aa change

mutant reads

coverage

VAF

FGFR3

NA

FGFR3-TACC3

900

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Clinical significance

ACVR1B

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.85G > A

V29I

9

218

0.04

Unknown significance

ADGRA2

c.G3010C

G1004R

43

782

0.06

NA

NA

NA

NA

NA

c.1883C > G

S628C

9

228

0.04

Unknown significance

AKT3

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.432A > G

T144T

8

111

0.07

Unknown significance

ARHGAP26

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.2155C > T

R719W

15

331

0.05

Confirmed somatic

ARID1A

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.352A > C

T118P

11

110

0.10

Unknown significance

c.780_782delCTC

S261del

16

179

0.09

Unknown significance

c.1040_1041insAGC

A347dup

13

154

0.08

Unknown significance

c.457C > G

P153A

9

191

0.05

Confirmed somatic

ARID1B

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.832G > A

G278S

23

272

0.09

Unknown significance

c.884G > A

C295Y

19

273

0.07

Unknown significance

c.1437G > A

M479I

7

131

0.05

Unknown significance

c.1189 T > G

S397A

5

172

0.03

Unknown significance

ATM

NA

NA

NA

NA

NA

c.2395G > A

A799T

13

162

0.08

NA

NA

NA

NA

NA

Confirmed somatic

CDK12

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1489G > T

A497S

11

172

0.06

Unknown significance

CDK6

NA

NA

NA

NA

NA

c.378G > T

M126I

6

151

0.04

c.378G > T

M126I

8

179

0.05

Unknown significance

CDK8

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.703C > T

H235Y

5

206

0.02

Unknown significance

CHD4

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.226A > T

M76L

6

69

0.09

Unknown significance

CREBBP

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.146_148delGAG

G49del

5

226

0.02

Unknown significance

CSNK1A1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.505A > C

T169P

5

178

0.03

Unknown significance

CUL3

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.464A > T

D155V

32

98

0.33

Unknown significance

DICER1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1A > T

M1L

7

90

0.08

Potential clinical significance

DPYD

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.170A > G

N57S

6

283

0.02

Unknown significance

c.229A > G

M77V

8

410

0.02

Unknown significance

EP300

c.670C > T

Q224*

628

969

0.65

c.670C > T

Q224*

27

95

0.28

c.670C > T

Q224*

137

143

0.96

Potential clinical significance

EPHA5

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1803A > T

E601D

5

106

0.05

Unknown significance

ERBB3

c.G2641C

E881Q

155

960

0.16

NA

NA

NA

NA

NA

c.2641G > C

E881Q

46

142

0.32

Unknown significance

ETV1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.68A > C

N23T

6

146

0.04

Unknown significance

EWSR1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.898A > T

M300L

6

82

0.07

Unknown significance

c.988A > C

M330L

6

142

0.04

Unknown significance

EXT1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.[876 T > C;877G > T]

[V292V;V293L]

12

453

0.03

Unknown significance

FAM135B

c.1898 T > A

L633*

257

975

0.26

c.1898 T > A

L633*

5

144

0.04

c.1898 T > A

L633*

67

318

0.21

Potential clinical significance

FANCD2

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.719C > A

S240*

8

164

0.05

Potential clinical significance

c.859C > T

H287Y

8

249

0.03

Unknown significance

FAT3

NA

NA

NA

NA

NA

c.6854C > A

P2285H

16

141

0.11

c.6854C > A

P2285H

61

303

0.20

Unknown significance

FLT1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.2515G > T

G839*

57

289

0.20

Unknown significance

FOXP1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1625A > T

K542I

12

150

0.08

Unknown significance

GATA6

c.G551A

S184N

26

338

0.08

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Potential clinical significance

GLI2

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.4112C > T

P1371L

6

197

0.03

Unknown significance

HRAS

c.A422C

Y141S

32

626

0.05

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Unknown significance

IGF2

c.20A > C

Q7P

94

445

0.21

c.20A > C

Q7P

12

153

0.08

c.20A > C

Q7P

105

217

0.48

Unknown significance

IKZF1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.346G > C

D116H

6

276

0.02

Unknown significance

KAT6A

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.4769G > T

G1590V

20

349

0.06

Unknown significance

KDM5A

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.396G > A

M132I

10

304

0.03

Unknown significance

KDM6A

c.2700_2724del

H848Qfs*11

499

1026

0.49

c.2700_2724del

H900Qfs*11

46

318

0.15

c.2700_2724del

H900Qfs*11

260

267

0.97

Potential clinical significance

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.2327 T > C

I776T

12

156

0.08

Unknown significance

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1423 T > C

S475P

8

113

0.07

Unknown significance

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.2038G > A

A680T

9

163

0.06

Unknown significance

LIMK1

NA

NA

NA

NA

NA

c.695G > A

R232Q

7

214

0.03

NA

NA

NA

NA

NA

Unknown significance

LRP1

NA

NA

NA

NA

NA

c.9730G > A

V3244I

5

213

0.02

NA

NA

NA

NA

NA

Confirmed somatic

NCOR1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.5609C > A

T1870N

14

150

0.09

Confirmed somatic

NF1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.4154A > G

K1385R

20

234

0.09

Unknown significance

NFIB

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1346G > C

S449T

13

292

0.05

Unknown significance

NKX2–1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.16A > G

S6G

5

219

0.02

Unknown significance

NRG3

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.2090G > A

E355D

6

128

0.05

Confirmed somatic

NSD1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.155_157dupCTG

T52ins

23

273

0.08

Unknown significance

c.158 T > C

V53A

5

152

0.03

Unknown significance

NTRK3

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1698A > T

P541S

27

101

0.27

Unknown significance

PLAG1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.53 T > C

V18A

10

245

0.04

Confirmed somatic

RANBP2

c.G3469C

D1157H

123

832

0.15

NA

NA

NA

NA

NA

c.2591C > A

D1157H

101

276

0.37

Unknown significance

RHOA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.209G > T

E186K

15

144

0.10

Unknown significance

SMARCA4

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.1930G > A

A1423A

7

277

0.03

Unknown significance

SSX1

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.358G > A

K153N

136

257

0.53

Unknown significance

TCF7L2

NA

NA

NA

NA

NA

c.670G > A

V224I

5

198

0.03

c.670G > A

S467A

13

172

0.08

Unknown significance

TEK

c.C3251A

S1084*

63

474

0.13

NA

NA

NA

NA

NA

c.2932G > A

S1084*

40

129

0.31

Unknown significance

TERT

NA

NA

NA

NA

NA

c.1520A > T

E507V

21

348

0.06

c.2105C > T

E507V

130

645

0.20

Unknown significance

TP53

c.772G > A

E258K

235

460

0.51

c.772G > A

E258K

53

241

0.22

c.31G > A

E258K

121

128

0.95

Potential clinical significance

ZNF703

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

c.58A > G

G21ins

54

599

0.09

Unknown significance

  1. Note: Clinical significance were variations had been reported as functional variants in cancer samples with functional studies. Potential clinical significance was those predicted to be functional, mainly for those splicing site or truncation of tumor suppressor genes. Confirmed somatic were known somatic alterations in COSMIC but have no functional analysis study. Others were defined as Unknown significance